132 related articles for article (PubMed ID: 18352853)
1. Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines.
Prymula R; Plisek S
Expert Opin Biol Ther; 2008 Apr; 8(4):503-13. PubMed ID: 18352853
[TBL] [Abstract][Full Text] [Related]
2. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
Gatchalian S; Reyes M; Bernal N; Lefevre I; David MP; Han HH; Bock HL; Wolter J; Schuerman L
Hum Vaccin; 2005; 1(5):198-203. PubMed ID: 17012860
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.
Gatchalian SR; Ramakrishnan G; Bock HL; Lefevre I; Jacquet JM
Hum Vaccin; 2010 Aug; 6(8):664-72. PubMed ID: 20657177
[TBL] [Abstract][Full Text] [Related]
4. A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life.
Gatchalian S; Reyes M; Bermal N; Chandrasekaran V; Han HH; Bock HL; Lefevre I
Hum Vaccin; 2008; 4(1):60-6. PubMed ID: 18376148
[TBL] [Abstract][Full Text] [Related]
5. A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers.
Quiambao B; Van Der Meeren O; Kolhe D; Gatchalian S
Hum Vaccin Immunother; 2012 Mar; 8(3):347-54. PubMed ID: 22330958
[TBL] [Abstract][Full Text] [Related]
6. The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents.
Ortega-Barrìa E; Kanra G; Leroux G; Bravo L; Safary A; Lefevre I;
Vaccine; 2007 Dec; 25(50):8432-40. PubMed ID: 17961876
[TBL] [Abstract][Full Text] [Related]
7. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
8. Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial.
Espinoza F; Tregnaghi M; Gentile A; Abarca K; Casellas J; Collard A; Lefevre I; Jacquet JM
BMC Infect Dis; 2010 Oct; 10():297. PubMed ID: 20950456
[TBL] [Abstract][Full Text] [Related]
9. Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia.
Wong SL; Soosai P; Teoh YL; Han HH; Lefevre I; Bock HL
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):474-83. PubMed ID: 18564687
[TBL] [Abstract][Full Text] [Related]
10. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
11. The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule.
Chatterjee S; Rego SJ; D'Souza F; Bhatia BD; Collard A; Datta SK; Jacquet JM
BMC Infect Dis; 2010 Oct; 10():298. PubMed ID: 20950457
[TBL] [Abstract][Full Text] [Related]
12. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America.
Tregnaghi M; López P; Rocha C; Rivera L; David MP; Rüttimann R; Schuerman L
Rev Panam Salud Publica; 2006 Mar; 19(3):179-88. PubMed ID: 16640847
[TBL] [Abstract][Full Text] [Related]
13. DTPw-HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children.
Santos JI; Martin A; De Leon T; Rivera L; Gaitán ME; Del Rio C; Oselka G; Cervantes Y; Rubio P; Clemens SA; de Mendonça JS
Vaccine; 2002 Mar; 20(13-14):1887-93. PubMed ID: 11906779
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants.
Kanra G; Kara A; Demiralp O; Contorni M; Hilbert AK; Spyr C; Viviani S
Hum Vaccin; 2006; 2(4):155-60. PubMed ID: 17012890
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and reactogenicity of combined versus separately administered DTPw-HBV and Hib vaccines given to healthy infants at 2, 4 and 6 months of age, with a booster at 18 months.
Riedemann S; Reinhardt G; Jara J; Rios R; Wenzel MS; Willems P; Bock HL
Int J Infect Dis; 2002 Sep; 6(3):215-22. PubMed ID: 12718838
[TBL] [Abstract][Full Text] [Related]
16. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa.
Vesikari T; Rivera L; Korhonen T; Ahonen A; Cheuvart B; Hezareh M; Janssens W; Mesaros N
Hum Vaccin Immunother; 2017 Jul; 13(7):1505-1515. PubMed ID: 28340322
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants.
Bavdekar SB; Maiya PP; Subba Rao SD; Datta SK; Bock HL
Indian Pediatr; 2007 Jul; 44(7):505-10. PubMed ID: 17684303
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule.
Avdicová M; Prikazský V; Hudecková H; Schuerman L; Willems P
Eur J Pediatr; 2002 Nov; 161(11):581-7. PubMed ID: 12424582
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
